• News Archive
  • Simaster
  • Webmail
  • Directory
  • Crisis Center
  •  English
    • Indonesia
Universitas Gadjah Mada Universitas Gadjah Mada Universitas Gadjah Mada Universitas Gadjah Mada
  • Education
    • Doctoral dissertation
    • Inauguration of Professor
    • Graduation
  • Achievement
  • Research and Innovation
    • Research
    • Innovation
  • Campus Info
    • Cooperation
    • Seminar and Workshop
    • Student Community Service Program
    • Other
  • News Report
  • Home
  • News Report
  • BPOM Approves Avivavir for Coronavirus Treatment

BPOM Approves Avivavir for Coronavirus Treatment

  • 29 March 2021, 11:58 WIB
  • By: Natasa Adelayanti
  • 1835
Mengenal Avifavir Sebagai Obat Covid-19

The National Agency of Drug and Food Control (NA-DFC), usually known as BPOM of Indonesia, has recently approved an Emergency Use Authorization (EUA) for Avivavir Covid-19 drugs. Clinical Pharmacologist and Pharmacist ugm, Prof. Apt. Zullies Ikawati, Ph.D., revealed this drug was considered a favipiravir-based drug made by Russia. It was made of Favipiravir, an antiviral drug to prevent influenza or anti-influenza. Since 2004, Japan has actually developed this drug. Favipiravir is a repurposing drug or reusing old-manufactured drugs for new indications, precisely for Covid-19. Since the Covid-19 began, Indonesian citizens have started to consume it as a Covid-19 therapy guideline. The drug works by inhibiting the production of viral RNA, which in turn inhibits viral replication.

"So, it isn't a new production. Japan has once developed it as an anti-influenza drug, but it no longer has a patent period. So, after that, several pharmaceutical industries in several countries around the world such as India, China, also Russia reproduced it using a different brand name and used for COVID, as well as to get emergency use authorization (EUA) in some countries” she said, Monday (29/3).

The UGM Faculty of Pharmacy Professor revealed this drug use only for Covid-19 patients with moderate to severe symptoms. The use of this product should also be under its therapy guideline and doctor's prescription.

Zullies added that this drug could not be found easily in the market because it had limited stock. Those were only exclusively available at particular Covid-19 referral hospitals.

"Public is not recommended to buy this product because it is not for sale. This drug is only assigned to Covid-19 patients with moderate and severe symptoms. If one gets infected with Covid-19, please immediately go to the doctor, get their advice in undergoing treatment," she explained.

Author: Ika
Photo: Illustration

 

Related News

  • UGM Professor Reckons Eucalyptus Necklace Is Not Yet Proven As Anti-Covid-19

    Monday,06 July 2020 - 17:57
  • Doctor of UGM Academic Hospital Shares Tips to Prevent Coronavirus Air Transmission

    Tuesday,28 July 2020 - 14:39
  • UGM Academic Hospital Doctor: Scuba Masks Ineffective to Prevent Covid-19

    Friday,18 September 2020 - 15:55
  • UGM Expert: Clinical Trials, the Way to Prove Covid-19 Vaccines Effectiveness in Indonesia

    Thursday,23 July 2020 - 13:21
  • Challenge in Vaccine Progress: Coronavirus Continues to Mutate

    Friday,22 May 2020 - 16:38

News Releases

  • Geography Alumna’s Aromatic Telon Oil Habbie Named 2023 Indonesia Brand Champion 03 February 2023
    Novita Anggraeni, an alumna of the UGM Faculty of Ge
    Salma
  • Bimasakti UGM Kicks Off Hybrid Technology Research 03 February 2023
    Bimasakti UGM has started researching hybrid technol
    Salma
  • 18,964 UGM Students Receive Scholarships, Director of Student Affairs Says 20 January 2023
    Universitas Gadjah Mada (UGM) annually allocates hundreds
    Salma
  • Prof. Budi Setiadi Daryono Recounts Origin of His Apple Melon Cultivar 'Hikapel' 16 January 2023
    In 2012, a team of researchers from the UGM Facult
    Salma
  • UGM Graduate Fajar Kelana Named Top 20 International James Dyson Award Winner 13 January 2023
    Fajar Sidik Abdullah Kelana, an alumnus of UGM and
    Salma

Event

No latest event at this time

Universitas Gadjah Mada
UNIVERSITAS GADJAH MADA
Bulaksumur Yogyakarta 55281
   info@ugm.ac.id
   +62 (274) 588688
   +62 (274) 565223
   +62 811 2869 988

PARTNERSHIP

  • Alumni
  • International Affairs

ABOUT UGM

  • Rector's Welcome
  • History
  • Vission and Mission
  • The Board of Executive
  • Management

VISIT UGM

  • Campus Map
  • Event

REGISTRATION

  • Undergraduate
  • Graduate
  • Vocational School
  • Professional Program
  • International Program

© 2023 Universitas Gadjah Mada

PRIVACY POLICYCONTACT